rense.com




WHO Charts Disturbing
Changes In Avian
Influenza Virus

From Patricia Doyle, PhD
dr_p_doyle@hotmail.com
5-23-5
 
Hello, Jeff - Some strains of HPAI are developing a resistance to tamiflu the standard treatment for the virus.
 
I seem to remember Professor Kawaoka whose team was working on pandemic strain of Spanish Flu calling for drop in BSL level from BSL 4 to BSL 3.
 
He asserted that because we have "Tamiflu" (oseltamivir) we can lower the Biosafety level.
 
The situation with Avian Flu A H5N1 strains becoming resistant to tamiflu should remind us that Influenza can quickly mutate and we must remember that our known medications cannot be relied upon.
 
Patricia Doyle
 
WHO Charts Disturbing Changes In Avian Influenza Virus
 
By Helen Branswell
Canadian Press - Canada.com
5-22-5
 
The World Health Organization urged countries to make full haste with pandemic influenza preparations on Wed 18 May 2005, as it released a report outlining disturbing changes to the H5N1 virus circulating in Asia. The report raises concerns that molecular and disease pattern evidence may indicate the virus is becoming more adept at infecting people. It also reveals some strains of the H5N1 virus may be developing resistance to oseltamivir, the drug wealthy nations are flocking to stockpile as fears of a pandemic mount.
 
An influenza expert who helped draft the report said it's meant to convey the message that the level of anxiety regarding the virus has risen. I think it's fair to say that the report signifies a definite step up in concern," said Dr. Keiji Fukuda, a flu specialist from the U.S. Centers for Disease Control who is being seconded to WHO's global influenza program.
 
The report concedes the authors had limited scientific evidence on which to determine whether H5N1 is becoming an even graver risk to mankind. "We're basically worried that that's what is happening, but we're also saying that there's not quite enough information available, not quite enough data and cases and patterns to really solidly say that is the case," Fukuda said from Atlanta. Fukuda was part of a recent 3-person WHO mission to Viet Nam, where the alarming changes are being observed in the northern part of the country. His team reported last week to a meeting of international experts in Manila; the report was drawn up from their deliberations.
 
A leading U.S. epidemiologist said the report contains no single smoking gun to suggest H5N1 is becoming a pandemic strain, but the combined evidence paints a compelling picture that cannot be ignored. "I think it tells us that everything about H5N1 is headed in the direction that none of us would like to see it go," said Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy [CIDRAP] at the University of Minnesota. "Do I say that that's going to mean there's an impending pandemic? I don't know that. Does it tell me that ... there's a growing concern about it? Absolutely."
 
The report of a case in which the virus was partially resistant to oseltamivir will give public health officials around the world pause. Oseltamivir (sold as Tamiflu) is one of only 2 antiviral drugs known to work against H5N1 and is the 1st choice for pandemic planners, because it is easier to use [can be taken by mouth] than the alternative, zanamivir, which is not licensed in Canada. Dr. Frederick Hayden, an antiviral expert at the University of Virginia, insisted it wasn't necessarily disturbing to find limited resistance to the drug, because it has also been documented in a small percentage of infections with human flu strains. Still, the finding raises the specter of a resistant strain of the virus becoming dominant and spreading among people, creating a situation in which the world has virtually no therapeutic weapons to combat pandemic flu in the months before a vaccine could be produced. Hayden noted that human flu strains resistant to oseltamivir are generally less fit and don't transmit as well. But Dr. Earl Brown, an influenza virologist at the University of Ottawa, said oseltamivir is too new a drug for anyone to assume that pattern will persist across all subtypes of influenza. "The indications from the lab data are that the virus is sort of a wimpier virus when it's resistant to the drug," he said. "So if that's always the case, that's good. But I think, given limited experience with the drug, you can't be too categorical at this point."
 
Fukuda said the authors of the report felt the situation demands close observation. "It's definitely a warning sign that we need to monitor resistance to oseltamivir," he said. "Clearly, that's what we have to do." The report also outlined the disturbing changes in infection patterns in northern Viet Nam, where this spring, there have been more clusters of cases, clusters that lasted for longer periods of time, and a greater age range among human cases. The changing patterns suggest the virus has altered. Among the possibilities is that the genetic mutations have allowed the virus to be transmitted more easily to people in the 1st place, or among them after a 1st case occurs. At the same time, molecular analysis of the virus shows genetic changes near what's known as the "receptor binding site," the point where the invading virus attaches to the cell walls of a host.
 
Influenza viruses comprised entirely of avian influenza genes don't tend to bind well to human receptor binding sites. But these changes may indicate the virus is evolving to be a better fit. Still, given how little is known about influenza, no one can predict with certainty the implications of these changes.
 
"The information is pretty sketchy," said Dr. Frank Plummer, scientific director of Canada's National Microbiology Laboratory in Winnipeg, which sent a team of 3 scientists to Hanoi on Wednesday [18 May 2005]. "And till we know quite a bit more, it's hard to know whether these things are real or not." The team, led by Dr. Yan Li, chief of the influenza laboratory, will help scientists at Viet Nam's National Institute of Hygiene and Epidemiology analyze blood samples from contacts of H5N1 cases to determine whether additional undetected infections have occurred. "It will help a lot in, I think, clarifying the extent of infection," Plummer said.
 
--
ProMED-mail
 
(Apart from information on the appearance of resistance to the anti-neuraminidase drug -- oseltamivir --, this report adds little to previous comments on the WHO Consultation Document
 
http://www.who.int/csr/disease/avian_influenza/H5N1
%20Intercountry%20Assessment%20final.pdf
 
which summarized the outcome of the WHO Meeting in Manila in early May 2005. The risk of a major pandemic of influenza remains unquantifiable. There have been more apparent clusters of human avian influenza virus infection in the north of Viet Nam than in the south of Vet Nam or elsewhere, but in virtually all situations, there has been exposure to or consumption of diseased chickens. There is still no firm evidence that the H5N1 virus transmits directly from human-to-human, although this possibility cannot be excluded. Although the avian influenza viruses isolated from humans appear to be more heterogenous in terms of the nucleotide sequence of the hemagglutinin gene (which encodes the virus protein that binds to the virus receptor on the surface of host cells), it should not be concluded that the virus may be changing to a form capable of human-to-human transmission. There is no directionality in virus variation unless there is an external selective force favoring a particular change. It is possible that a virus capable of transmission between humans may evolve by chance, but there is no reason to suppose that such a virus evolving by mutation alone would be exceptionally virulent, rather the reverse. In the H7N7 avian influenza outbreak in the Netherlands in 2003, many poultry workers developed mild infections (conjunctivitis) with very limited spread to household contacts, but no pandemic ensued. The greatest risk remains the generation of a novel human pathogen by reassortment of genes between the H5N1 avian virus and human influenza viruses. - Mod.CP)
 
Patricia A. Doyle, PhD
 
Please visit my "Emerging Diseases" message board at: http://www.clickitnews.com/ubbthreads/postlist.php?
Cat=&Board=emergingdiseases
Zhan le Devlesa tai sastimasa
Go with God and in Good Health
 

Disclaimer






MainPage
http://www.rense.com


This Site Served by TheHostPros